PA8559001A1 - Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo - Google Patents

Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo

Info

Publication number
PA8559001A1
PA8559001A1 PA20028559001A PA8559001A PA8559001A1 PA 8559001 A1 PA8559001 A1 PA 8559001A1 PA 20028559001 A PA20028559001 A PA 20028559001A PA 8559001 A PA8559001 A PA 8559001A PA 8559001 A1 PA8559001 A1 PA 8559001A1
Authority
PA
Panama
Prior art keywords
growth
oseo
promote
compounds
polymer compositions
Prior art date
Application number
PA20028559001A
Other languages
English (en)
Inventor
Francis Dumont
Richard Wilker Korsmeyer
Vishwas Madhav Paralkar
Richard Lee Dunn
Scott Alexander Jeffers
Mingxing Zhou
Mei Li
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8559001A1 publication Critical patent/PA8559001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN SISTEMA MEJORADO PARA LA LIBERACION CONTROLADA DE UN COMPUESTO QUE PROMUEVE EL CRECIMIENTO OSEO Y A UNA COMPOSICION FLUIBLE PARA SU FORMACION. LA COMPOSICION FLUIBLE ESTA COMPUESTA DE UN COMPUESTO QUE PROMUEVE EL CRECIMIENTO OSEO, UN POLIMERO TERMOPLASTICO Y UN DISOLVENTE ORGANICO. LA COMPOSICION FLUIBLE ES CAPAZ DE FORMAR UNA MATRIZ DE POLIMERO SOLIDA, MICROPOROSA, BIODEGRADABLE Y/O BIOEROSIONABLE. LA MATRIZ ES UTIL COMO IMPLANTE EN PACIENTES (SERES HUMANOS Y ANIMALES) PARA SUMINISTRAR A CIERTOS TEJIDOS UN COMPUESTO QUE PROMUEVE EL CRECIMIENTO OSEO.
PA20028559001A 2001-11-30 2002-11-28 Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo PA8559001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33725501P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
PA8559001A1 true PA8559001A1 (es) 2003-11-12

Family

ID=23319774

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028559001A PA8559001A1 (es) 2001-11-30 2002-11-28 Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo

Country Status (34)

Country Link
US (2) US20030104031A1 (es)
EP (1) EP1448166A1 (es)
JP (1) JP4903985B2 (es)
KR (1) KR100629380B1 (es)
CN (1) CN1599598A (es)
AP (1) AP1781A (es)
AR (1) AR037462A1 (es)
AU (2) AU2002347502A1 (es)
BR (1) BR0214610A (es)
CA (1) CA2468703C (es)
DO (1) DOP2002000534A (es)
EA (1) EA011350B1 (es)
EC (1) ECSP045124A (es)
GE (1) GEP20063951B (es)
GT (1) GT200200242A (es)
HR (1) HRP20040486A2 (es)
HU (1) HUP0402135A3 (es)
IL (1) IL161835A0 (es)
IS (1) IS7217A (es)
MA (1) MA27084A1 (es)
MX (1) MXPA04003723A (es)
NO (1) NO20042273L (es)
NZ (1) NZ533115A (es)
OA (1) OA12731A (es)
PA (1) PA8559001A1 (es)
PE (1) PE20030581A1 (es)
PL (1) PL370085A1 (es)
SV (1) SV2004001421A (es)
TN (1) TNSN04096A1 (es)
TW (1) TW200300695A (es)
UA (1) UA76792C2 (es)
WO (1) WO2003045351A1 (es)
YU (1) YU35004A (es)
ZA (1) ZA200402755B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
EP1596765A2 (en) * 2003-02-10 2005-11-23 Smith & Nephew, Inc. Resorbable devices
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8641738B1 (en) 2004-10-28 2014-02-04 James W. Ogilvie Method of treating scoliosis using a biological implant
US8123787B2 (en) 2004-10-28 2012-02-28 Ogilvie James W Method of treating scoliosis using a biological implant
CA2619571A1 (en) * 2005-08-18 2007-02-22 Smith & Nephew, Plc High strength devices and composites
CN100443065C (zh) * 2006-01-26 2008-12-17 上海交通大学 用于颌面骨缺损修复的复合体系植入体单元
CA2679365C (en) 2006-11-30 2016-05-03 Smith & Nephew, Inc. Fiber reinforced composite material
JP5416090B2 (ja) 2007-04-18 2014-02-12 スミス アンド ネフュー ピーエルシー 形状記憶ポリマーの膨張成形
EP2142227B1 (en) 2007-04-19 2012-02-29 Smith & Nephew, Inc. Multi-modal shape memory polymers
EP2150288B1 (en) 2007-04-19 2011-04-13 Smith & Nephew, Inc. Graft fixation
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
CN102119022B (zh) 2008-08-12 2015-09-09 诺华股份有限公司 药物组合物
EP2172189A1 (en) * 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
WO2010045487A1 (en) * 2008-10-15 2010-04-22 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via internal implants
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
EP2464389A2 (en) 2009-08-06 2012-06-20 Koninklijke Philips Electronics N.V. Oncology therapies employing radioactive seeds
US20130071403A1 (en) 2011-09-20 2013-03-21 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
CN104189954B (zh) * 2014-09-19 2017-03-29 中国科学院长春应用化学研究所 一种原位固化组织工程支架及其制备方法
RU2571548C1 (ru) * 2014-12-17 2015-12-20 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Ветеринарное имплантируемое средство пролонгированного действия (варианты)
SG11201804037XA (en) 2015-11-16 2018-06-28 Evonik Roehm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN114599372A (zh) 2019-11-04 2022-06-07 阿斯利康(瑞典)有限公司 用于治疗癌症的组合疗法
EP4255357A1 (en) 2020-12-29 2023-10-11 Sino Medical Sciences Technology Inc. Drug eluting stent
WO2024089418A1 (en) 2022-10-24 2024-05-02 Cancer Research Technology Limited Tumour sensitisation to checkpoint inhibitors with redox status modifier
WO2024089417A1 (en) 2022-10-24 2024-05-02 Memorial Sloan-Kettering Cancer Center Tumour stratification for responsiveness to an immune checkpoint inhibitor
WO2024150017A1 (en) 2023-01-13 2024-07-18 Akrivia Biomedics Limited Method of profiling diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2187355C (en) * 1994-04-08 2009-10-13 Richard L. Dunn An adjunctive polymer system for use with medical device
AU4652596A (en) 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
PT949905E (pt) * 1996-12-20 2001-12-28 Alza Corp Composicao de gel injectavel de efeito retardado e processo para a sua preparacao
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Also Published As

Publication number Publication date
HUP0402135A2 (hu) 2005-02-28
GEP20063951B (en) 2006-10-25
US8017144B2 (en) 2011-09-13
TW200300695A (en) 2003-06-16
AU2009200125A1 (en) 2009-02-05
CA2468703C (en) 2009-12-29
PE20030581A1 (es) 2003-07-08
HUP0402135A3 (en) 2008-04-28
KR20040062977A (ko) 2004-07-09
WO2003045351A1 (en) 2003-06-05
AU2009200125B2 (en) 2012-02-02
MXPA04003723A (es) 2005-04-08
NZ533115A (en) 2005-12-23
ZA200402755B (en) 2005-04-08
CN1599598A (zh) 2005-03-23
TNSN04096A1 (fr) 2006-06-01
AP2004003037A0 (en) 2004-06-30
EA011350B1 (ru) 2009-02-27
UA76792C2 (uk) 2006-09-15
JP2005515190A (ja) 2005-05-26
US20030104031A1 (en) 2003-06-05
DOP2002000534A (es) 2003-05-31
EA200400608A1 (ru) 2004-10-28
YU35004A (sh) 2006-08-17
EP1448166A1 (en) 2004-08-25
MA27084A1 (fr) 2004-12-20
ECSP045124A (es) 2004-07-23
AR037462A1 (es) 2004-11-10
IL161835A0 (en) 2005-11-20
OA12731A (en) 2006-06-28
US20090169595A1 (en) 2009-07-02
JP4903985B2 (ja) 2012-03-28
GT200200242A (es) 2003-06-25
AP1781A (en) 2007-09-27
CA2468703A1 (en) 2003-06-05
IS7217A (is) 2004-04-07
AU2002347502A1 (en) 2003-06-10
BR0214610A (pt) 2004-09-14
NO20042273L (no) 2004-07-14
PL370085A1 (en) 2005-05-16
SV2004001421A (es) 2004-05-07
HRP20040486A2 (en) 2004-10-31
KR100629380B1 (ko) 2006-09-29

Similar Documents

Publication Publication Date Title
PA8559001A1 (es) Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo
BR0012552A (pt) Dispositivo emissor de fragrância
ES2113906T3 (es) Composiciones polimericas utiles como implantes con administracion controlada.
WO2008098927A3 (en) Degradable reservoir implants
RS53890B1 (en) STABILIZED POLYMER DELIVERY SYSTEM
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
AR053968A1 (es) Composiciones de polimeros antimicrobianas de liberacion controlada
GT199900157A (es) Herbicidas novedosos.
CY1105647T1 (el) Γαλακτωματα για συστηματα απελευθερωσης in-situ
GT200500113A (es) Derivados de pirimidina para tratar el crecimiento celular anomalo
DE602007014277D1 (de) Zellselektive Implantatoberfläche mit gesteuerter Freisetzung bioaktiver Wirkstoffe
BR0117123A (pt) Dispositivo de retenção gástrica expansìvel
BRPI0500028A (pt) agente e método desodorizante
CU23352A1 (es) Biomateriales compuestos para implantes óseos
BRPI0409681A (pt) derivados de wortmanina solúveis em água
DE602006003824D1 (de) Stoffgemisch zur Beseitigung unangenehmer Gerüche
ES2163553T3 (es) Producto para el tratamiento de excrementos de animales.
GT200000110A (es) Controladores de hormigas y metodo para su aplicacion.
UY27555A1 (es) Composiciones polímeras de liberación controlada de compuestos que promueven el crecimiento óseo
AR056017A1 (es) Formulaciones de vacuna animal, metodo para preparar una formulacion de vacuna y componente estabilizador de vacuna
BR0215643A (pt) Adjuvante imunológico de tecido solidificado
PA8491201A1 (es) Procedimiento para preparar secretagogos de hormonas del crecimiento.
BR0016866A (pt) Composição anti-helmìntica com liberação sustentada
GT200200186A (es) Composicion herbicidas
HN2000000078A (es) Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina